Research from USC indicates semaglutide may reduce alcohol consumption by lowering cravings and heavy drinking days in a clinical trial.
USC Study Reveals Semaglutide’s Potential to Treat Alcohol Use Disorder
A recent clinical trial conducted by researchers at the University of Southern California (USC) suggests that semaglutide, a drug well-known for treating diabetes and obesity, could also help individuals reduce alcohol consumption. This finding, published in JAMA Psychiatry, opens up new possibilities for the treatment of alcohol use disorder, a condition affecting nearly one-third of American adults.
Alcohol use disorder takes a significant toll on public health. Annually, it contributes to approximately 178,000 deaths in the United States, increasing the risk of liver disease,
